Navigation Links
Virobay's Spectrum-Selective Cathepsin Inhibitor Shows Efficacy in Bone Cancer Model
Date:11/14/2011

MENLO PARK, Calif., Nov. 14, 2011 /PRNewswire/ -- Virobay, Inc., a privately held biotechnology firm with a broad portfolio of cysteine protease inhibitors for the treatment of autoimmune diseases, neuropathic pain, liver diseases and cancer, presented data showing that one of the company's spectrum-selective cathepsin inhibitors demonstrated efficacy in a mouse model of bone cancer pain.  Virobay has a series of advanced, spectrum-selective cathepsin inhibitors with structural diversity and demonstrated activity in bone cancer and related pain.  VBY-825, a prototype compound within this series, is an orally bioavailable, highly potent, reversible inhibitor of a subset of cathepsin proteases (including cathepsins S, K, L and B) that demonstrated protection from bone destruction and remodeling in this metastatic breast cancer model, as well as significant analgesic activity.  These preclinical data suggest that Virobay's spectrum-selective cathepsin inhibitors have potential therapeutic utility in the treatment of metastatic and primary bone cancer and cancer-related bone pain, with a mechanism of action that would be highly complementary to standard chemotherapy.

The data were presented in a poster, titled "Efficacy of a Spectrum-Selective Cathepsin Inhibitor in a Mouse Model of Bone Cancer," by Holsinger, et al., at the AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics, on Sunday, November 13th.

"These preclinical data provide a compelling demonstration of the therapeutic potential of Virobay's cathepsin inhibitors in bone cancer and bone cancer pain," said Robert Booth, PhD, Virobay's president and chief executive officer.  "The data demonstrate that the anti-tumorigenic and analgesic activity is due to the selective targeting of specific cathepsins that are known to facilitate osteolytic metastasis, bone invasion and bone matrix degradation.  We believe that these dat
'/>"/>

SOURCE Virobay, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. ChemoCentryx Presents Positive Results for Novel CCR2 Inhibitor in Preclinical Models of Diabetic Nephropathy at the 44th Annual Meeting of the American Society of Nephrology
2. Study Shows C1-Esterase Inhibitor Concentrate is Safe and Consistently Effective for Long-Term Treatment of Hereditary Angioedema Attacks at Any Body Location
3. Karyopharm Therapeutics Closes $10 Million Series A2 Financing to Expand Planned Phase 1 Program of Oral Selective Inhibitors of Nuclear Export (SINE) for Cancer
4. ViiV Healthcare Starts Phase III Clinical Programme of Celsentri/Selzentry® (maraviroc) versus Truvada® (tenofovir + FTC), in combination with a Protease Inhibitor in people living with HIV
5. Enantas Lead NS5A Inhibitor Candidate for HCV, EDP-239, Selected as One of Windhovers Top 10 Infectious Disease Projects to Watch
6. Debiopharm and Ascenta Therapeutics, Inc. Announce An Exclusive License Agreement for the Development and Commercialization of the IAP (Inhibitor of Apoptosis Protein) Inhibitor AT-406 (Called Debio 1143 by Debiopharm) for the Treatment of Various T
7. Modulation of inhibitory output is key function of antiobesity hormone
8. Neurocrine Biosciences Announces Notice of Allowance for Composition of Matter Patent on VMAT2 Inhibitor
9. Interleukin-6 Inhibitor Sirukumab (CNTO 136) Phase 2 Data Show Promise in the Treatment of Active Rheumatoid Arthritis
10. Ardea Biosciences Announces Data on MEK Inhibitor BAY 86-9766 (RDEA119) to be Presented at 2011 American Society of Clinical Oncology Annual Meeting
11. Pharmacyclics Achieves $7 Million Development Milestone for HDAC Inhibitor, PCI-24781 / S 78454 with Servier
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... what they believe is the thinnest-possible semiconductor, a ... only three atoms thick. , The University of ... single-layer semiconductor materials can be connected in an ... result could be the basis for next-generation flexible ... and solar technologies. , "Heterojunctions are fundamental elements ...
(Date:8/26/2014)... , Aug. 26, 2014 An analysis by ... of all Mers CoV virus strains has ... back to 2012.  This conservation and sharing of specific ... Synthetic Mers CoV Blocker-Vaccine™ candidate, as it did for the ... both of which have been found to be effective ...
(Date:8/26/2014)... added to the growing case for graphene being ... thing in the high-tech world by the two-dimensional ... of researchers led by a scientist with the ... Laboratory (Berkeley Lab) has reported the first experimental ... materials. The recorded charge transfer time clocked in ...
(Date:8/26/2014)... Ga. , Aug. 26, 2014  ViveBio, ... biological sample collection, stabilization and transportation, announced today ... Laboratory Procurement Services, LLC (LPS) of ... of products in the United States ... new class of ambient temperature dried biological specimen ...
Breaking Biology Technology:Scientists craft atomically seamless, thinnest-possible semiconductor junctions 2Competition for graphene 2ViveBio and Laboratory Procurement Services Sign Agreement for Distribution of the ViveST Line of Products 2
... For Rejection Of Legislation That Will Cost Vermonters Current ... to the Legislature and a full page ad in ... that a bill under consideration by the Vermont Legislature ... for biotechnology growth and development not only in New ...
... April 24 Dendreon Corporation (Nasdaq: DNDN ... at the American Urological Association,s (AUA) Annual Meeting in ... conference call:, , ... CDT - "A randomized, double-blind, placebo-controlled, multi-center, phase III ...
... April 23 Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ... Lead Independent Director, on behalf of the Amylin Board of ... Carl Icahn and Eastbourne Capital Management, L.L.C. to find a ... can reach a resolution that will be in the best ...
Cached Biology Technology:Regional Biotech Association Warns Legislation Would Make VT Least Friendly State in Nation for Biotechnology and Life Sciences 2Dendreon Announces Data Presentations and Webcast at AUA Annual Meeting 2Amylin Issues Statement in Response to Carl Icahn 2
(Date:8/26/2014)... environmental and social problems such as global warming ... or does the burden fall on our failure ... to a new study in the Journal ... burden for solving global problems from governments to ... , "When businesses convince politicians to encourage responsible ...
(Date:8/26/2014)... People for the Ethical Treatment of Animals (PETA) and ... be in Prague this week at the 9th World ... Sciences presenting original research on alternatives to the use ... well as studies identifying problems with current laboratory oversight ... from August 24 to 28, 2014, PETA and PISC ...
(Date:8/25/2014)... years ago this month, one of the first U.S. ... State University campus, striking some 2,000 people. A university ... data gathered at the time to gain insight into ... virus,s rapid spread across the university community., The fall ... came in to the university,s Health and Wellness Services ...
Breaking Biology News(10 mins):An inconvenient truth: Does responsible consumption benefit corporations more than society? 2WSU flu outbreak provides rare study material 2WSU flu outbreak provides rare study material 3
... release is available in Spanish . First ... stink bug (BMSB) is now in at least 39 states, is ... threat to orchard fruits, garden vegetables and row crops. It,s no ... its top "invasive insect of interest." But help may ...
... 2013) Autism Speaks, the world,s leading autism science ... million in funding for 14 new research projects. To ... for research projects that advance understanding of the causes, ... "Autism Speaks continues in its steadfast ...
... Even as policy makers and health experts point to an ... and universities in the United States have dropped physical education ... student was required to take physical education and exercise requirements ... low of 39 percent, according to a new study. ...
Cached Biology News:Combating USDA's top-ranked invasive insect 2Autism Speaks awards $4.8 million for new research 2Autism Speaks awards $4.8 million for new research 3Autism Speaks awards $4.8 million for new research 4Autism Speaks awards $4.8 million for new research 5Physical education requirement at 4-year universities at all-time low 2Physical education requirement at 4-year universities at all-time low 3
... porcine) Endogenous potent vasoconstrictor peptide. ... and modulates vascular tonus. ET-1, ET-2, and ... endothelin genes. ET-2 and ET-3 are similar ... six amino acids, respectively. All three isopeptides ...
... provide two highly efficient methods of identifying ... preparation. By using the large-scale screen method ... do is to transfer partial colonies of ... plates into the solutions provided by the ...
GLP-1 (HYB 147-12)...
... KLH-conjugated, synthetic peptide corresponding to ... mouse p19ARF. The epitope ... 62-75. Clone 5-C3-1. Quality ... immunoblot. Stability ...
Biology Products: